Default: Journal of Hypertension

ISSN: 0263-6352

Journal Home

Journal Guideline

Journal of Hypertension Q1 Unclaimed

Lippincott Williams and Wilkins Ltd. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Hypertension is a journal indexed in SJR in Physiology and Internal Medicine with an H index of 172. It has an SJR impact factor of 1,249 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,249.

Journal of Hypertension focuses its scope in these topics and keywords: pressure, blood, treatment, hypertensive, hypertension, ischemic, type, stroke, risk, vascular, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Journal of Hypertension

1,249

SJR Impact factor

172

H Index

381

Total Docs (Last Year)

1073

Total Docs (3 years)

6853

Total Refs

2787

Total Cites (3 years)

779

Citable Docs (3 years)

2,47

Cites/Doc (2 years)

17,99

Ref/Doc

Other journals with similar parameters


Circulation Q1
Circulation Research Q1
Nature Metabolism Q1
Sleep Medicine Reviews Q1
BMC Biology Q1

Compare this journals

Aims and Scope


pressure, blood, treatment, hypertensive, hypertension, ischemic, type, stroke, risk, vascular, oxidative, patients, stiffness, stress, study, survey, nox, monitoring, heart, assessment, atrial, autonomic, antihypertensive, clinical, control, damage, effects, european, fit, health,



Best articles by citations

Left atrial size in hypertension and stroke

View more

Relationship between C reactive protein and pulse pressure is not mediated by atherosclerosis or aortic stiffness

View more

Easy-to-use tool for evaluating the elevated acute kidney injury risk against reduced cardiovascular disease risk during intensive blood pressure control

View more

The finger volume pulse and assessment of arterial properties

View more

A comparison of enalapril 20 mg once daily versus 10 mg twice daily in terms of blood pressure lowering and patient compliance

View more

Residual coronary risk in men aged 50-59 years treated for hypertension and hyperlipidaemia in the population

View more

Hypertension in Diabetes Study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients

View more

Erratum

View more

Smoking is bad for you

View more

Home blood pressure monitoring

View more

Arterial mechanics and wave reflection with antihypertensive therapy

View more

Functionality of two new polymorphisms in the human renin gene enhancer region

View more
SHOW MORE ARTICLES

Influence of vitamin D receptor gene polymorphisms and 25-hydroxyvitamin D on blood pressure in apparently healthy subjects

View more

Serum cholesterol levels, blood pressure response to stress and incidence of stable hypertension in young subjects with high normal blood pressure

View more

Short-term reproducibility of a non-dipping pattern in type 2 diabetic hypertensive patients

View more

The accuracy of automated blood pressure measuring devices in patients with controlled atrial fibrillation

View more

Endothelial function affects early carotid atherosclerosis progression in hypertensive postmenopausal women

View more

Interaction of haemodynamic and metabolic pathways in the genesis of diabetic nephropathy

View more

Hypertension prevalence, control and survivorship in an Afro-Caribbean population

View more

Serial assessment of cardiovascular control shows early signs of developing pre-eclampsia

View more

Altered plasma fibrin clot properties in hypertensive patients with obstructive sleep apnoea are improved by continuous positive airway pressure treatment

View more

Detection of Renin Messenger RNA in Rat Tissues: Increased Sensitivity Using an RNAse Protection Technique

View more

Enhanced blood pressure and appetite responses to chronic central melanocortin-3/4 receptor blockade in dietary-induced obesity

View more

Highlights of the February issue

View more

Comments

No comments ... Be the first to comment!

FAQS